Evolocumab Therapy Reduces Intracranial Atherosclerotic Plaque
A recent clinical trial has revealed that adding evolocumab to standard statin therapy significantly enhances plaque regression in patients with intracranial atherosclerotic stenosis (ICAS). Over a six-month period, patients receiving…